Skip to main content
Journal cover image

Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity

Publication ,  Conference
Rogers, J; Bloch, R; Eudy, A; Pisetsky, D; Alexander, R; Conklin, J; Sun, K; Sadun, R; Criscione-Schreiber, L; Doss, J; Clowse, M
Published in: ARTHRITIS & RHEUMATOLOGY
2021

Duke Scholars

Published In

ARTHRITIS & RHEUMATOLOGY

EISSN

2326-5205

ISSN

2326-5191

Publication Date

2021

Volume

73

Start / End Page

1800 / 1802

Related Subject Headings

  • 3204 Immunology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rogers, J., Bloch, R., Eudy, A., Pisetsky, D., Alexander, R., Conklin, J., … Clowse, M. (2021). Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity. In ARTHRITIS & RHEUMATOLOGY (Vol. 73, pp. 1800–1802).
Rogers, Jennifer, Rory Bloch, Amanda Eudy, David Pisetsky, Roberta Alexander, John Conklin, Kai Sun, et al. “Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity.” In ARTHRITIS & RHEUMATOLOGY, 73:1800–1802, 2021.
Rogers J, Bloch R, Eudy A, Pisetsky D, Alexander R, Conklin J, et al. Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity. In: ARTHRITIS & RHEUMATOLOGY. 2021. p. 1800–2.
Rogers, Jennifer, et al. “Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity.” ARTHRITIS & RHEUMATOLOGY, vol. 73, 2021, pp. 1800–02.
Rogers J, Bloch R, Eudy A, Pisetsky D, Alexander R, Conklin J, Sun K, Sadun R, Criscione-Schreiber L, Doss J, Clowse M. Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity. ARTHRITIS & RHEUMATOLOGY. 2021. p. 1800–1802.
Journal cover image

Published In

ARTHRITIS & RHEUMATOLOGY

EISSN

2326-5205

ISSN

2326-5191

Publication Date

2021

Volume

73

Start / End Page

1800 / 1802

Related Subject Headings

  • 3204 Immunology
  • 3202 Clinical sciences